We seek ...
- Opportunities in the innovative segment of CNS (epilepsy, Parkinson’s disease, orphamns and CNS niche disorders)
- Late-stage clinical projects (for co-development and commercialization)
- Branded pharmaceuticals
- Innovative technologies
- Marketing collaborations either pan-European or within select European territories
